M

Marta Naidenova

About

Detail

Founders' Office
London, England, United Kingdom

Timeline


work
Job

RΓ©sumΓ©


Jobs verified_user 0% verified
  • DolarApp
    Founders' Office @ DolarApp
    DolarApp
    Sep 2025 - Current (11 months)
    Operations and customer experience
  • DolarApp
    Founders' Office
    DolarApp
    Aug 2025 - Current (1 year)
  • ARQ
    Founders' Office
    ARQ
    Aug 2025 - Current (1 year)
    Product and operations for customer experience. Formerly DolarApp.
  • Various Startups
    Angel Investor
    Various Startups
    Dec 2023 - Current (2 years 8 months)
    Personal investments in a range of pre-seed to Series A startups, including Dex, MyEdSpace, Cori Clinical, Paypercut, Tendify (fka TrustPath), RecurseML, Sunbeam and 4x more in stealth
  • L
    Limited Partner
    Jan 2023 - Current (3 years 7 months)
    The angel fund by Pietro Invernizzi, investing Β£100-250K checks in European founders
  • V
    Venture Capital Investor
    Jan 2021 - Jan 2025 (4 years 1 month)
    UK, Ireland and CEE market lead, focussed on tech investing at seed/Series A. Promoted from Associate to VP. Board observer and investor at Mondoo (cybersecurity), Digitail (vSaaS for vets), Scarlet (regtech) & Accurx (vSaaS for healthcare). Also involved in the investments and/or portfolio management of Hinge Health (NYSE: HNGE), Pelago, Qatalog (acquired).
  • JP Morgan
    Investment Banking
    JP Morgan
    Jan 2018 - Jan 2021 (3 years 1 month)
    Worked with publicly listed and late stage private companies in the Technology, Media & Telecoms (TMT) space on M&A advisory and debt/equity financing, with a focus on high-growth technology businesses
Education verified_user 0% verified
  • UniversitΓ  Bocconi
    BSc International Economics and Finance
    UniversitΓ  Bocconi
    Accepted with a full merit-based scholarship, and retained it over the 3-year degree
  • I
    International High School
    Graduated summa cum laude (highest distinction) with dual American and Bulgarian diplomas
This is a community-created genome.